Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)

Next Previous
X
Search
Trial Profile

A Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 07 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Muscle-derived autologous stem cell therapy Bioheart (Primary)
  • Indications Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms MARVEL
  • Sponsors U.S. Stem Cell

    • Most Recent Events

    • 20 Jul 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2019.
    • 26 Jan 2015 According to the ClinicalTrials.gov record, planned changed from 1 Feb 2012 to 1 Feb 2017.
    • 26 Jan 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Feb 2014 to 1 Feb 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top